Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,087 | 113,207 | 78,537 | 59,248 | 92,372 |
| Marketable Securities | 162,708 | 122,389 | 162,427 | 235,607 | 235,982 |
| Receivables | 3,328 | 1,707 | 862 | 1,025 | N/A |
| Inventories | N/A | N/A | N/A | 111 | N/A |
| TOTAL | $361,874 | $249,332 | $253,449 | $308,387 | $335,636 |
| Non-Current Assets | |||||
| PPE Net | 2,426 | 2,559 | 2,722 | 2,813 | 2,956 |
| Intangibles | 8,097 | 8,311 | 8,527 | 4,658 | 4,772 |
| Other Non-Current Assets | 17,217 | 17,473 | 20,126 | 13,665 | 12,459 |
| TOTAL | $27,740 | $28,343 | $31,375 | $21,136 | $20,187 |
| Total Assets | $389,614 | $277,675 | $284,824 | $329,523 | $355,823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,933 | 6,012 | 12,010 | 5,737 | 4,614 |
| Accrued Expenses | 25,741 | 35,605 | 25,199 | 30,084 | 18,265 |
| Other current liabilities | N/A | N/A | 9,440 | N/A | N/A |
| TOTAL | $33,098 | $44,570 | $47,274 | $43,427 | $23,467 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,760 | 2,309 | N/A | 7,000 | N/A |
| Other Non-Current Liabilities | 2,360 | 3,204 | 1,781 | 1,945 | 2,104 |
| TOTAL | $75,321 | $37,477 | $1,781 | $1,945 | $10,093 |
| Total Liabilities | $108,419 | $82,047 | $49,055 | $45,372 | $33,560 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,348 | 50,721 | 50,394 | 50,330 | 50,268 |
| Common Shares | 56 | 50 | 50 | 50 | 50 |
| Retained earnings | -667,565 | -626,704 | -581,703 | -528,939 | -486,073 |
| Other shareholders' equity | -339 | -906 | -629 | -1 | 21 |
| TOTAL | $281,195 | $195,628 | $235,769 | $284,151 | $322,263 |
| Total Liabilities And Equity | $389,614 | $277,675 | $284,824 | $329,523 | $355,823 |